Omnicell Value Stock - Dividend - Research Selection
Market price: 137,05 USD
Omnicell Fundamental data and company key figures of the share
|Annual reports in USD|
|Net operating cash flow||185.870.000|
|Free cash flow||131.004.000|
|Liabilities & Shareholders equity||1.824.500.000|
|Diluted shares outstanding||43.743.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||5.994.978.304,00 USD|
|Raw Data Source||US GAAP in Millionen USD|
Description of the company
Omnicell, Inc. (Omnicell) is a provider of automated solutions for hospital medication and supply management. The Company´s automation and analytics solutions are designed to enable healthcare facilities to acquire, manage, dispense and administer medications and medical-surgical supplies. Its systems provide medication control and dispensing solution starting from the point of entry into the hospital and other health care providers, through the central pharmacy, to the nursing station and to the patient´s bedside. Omincell´s medication-use product line includes its OmniRx, SinglePointe, AnywhereRN, Anesthesia Workstation, WorkflowRx, Controlled Substance Management, OmniLinkRx, Savvy Mobile Medication System, and Pandora Data Analytics products. In May 2012, the Company acquired MTS Medication Technologies, Inc.